Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medigene AG | -4.620% | -0.656% | -23.678% | -7.903% | -4.717% | -60.853% | -82.166% |
| BioMarin Pharmaceutical Inc. | -4.600% | -3.802% | -14.213% | -15.624% | -15.835% | 16.604% | 4.027% |
| Pharmaxis Ltd. | -4.550% | - | - | - | - | - | - |
| Enlivex Therapeutics Ltd. | -4.510% | -8.276% | -1.481% | -46.800% | -40.625% | -81.655% | - |
| Arovella Therapeutics Ltd. | -4.480% | -4.286% | 8.065% | 71.795% | -0.741% | 346.667% | -10.667% |
| ConvaTec Group PLC | -4.460% | 6.081% | -5.422% | 21.705% | 9.790% | 30.833% | - |
| Trinity Biotech ADR | -4.440% | - | - | - | - | - | - |
| Immutep LTD ADR | -4.410% | -7.143% | 19.266% | 80.556% | 19.266% | -10.959% | -9.408% |
| AB Science S.A. | -4.380% | 3.440% | -1.865% | -53.326% | -42.329% | -85.176% | -52.803% |
| Atara Biotherapeutics Inc. | -4.370% | 11.061% | -10.027% | -70.758% | 15.583% | -94.593% | - |
| Ligand Pharmaceuticals | -4.320% | 4.000% | 3.311% | 9.859% | 20.000% | -23.828% | -22.047% |
| Avita Medical Ltd | -4.320% | -1.765% | -13.021% | -24.091% | -34.766% | -50.882% | 479.861% |
| Redhill Biopharma Ltd ADR | -4.210% | - | - | - | - | - | - |
| Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |
| Elite Pharmaceut. | -4.110% | - | - | - | - | - | - |
| ImmunityBio Inc. | -4.060% | 0.868% | 51.005% | 151.351% | 57.627% | -40.174% | - |
| Epigenomics AG NA | -4.040% | - | - | - | - | - | - |
| China SXT Pharmaceuticals Inc. | -4.030% | - | - | - | - | - | - |
| Akari Therapeutics plc ADR | -3.980% | - | - | - | - | - | - |
| co.don AG | -3.980% | - | - | - | - | - | - |
| Immunovaccine Inc | -3.890% | - | - | - | - | - | - |
| Brainstorm Cell | -3.840% | 28.220% | -13.477% | -82.137% | 90.948% | -84.065% | - |
| Active Biotech AB | -3.810% | -1.159% | -31.800% | -25.055% | 14.047% | -70.140% | -87.083% |
| Chimerix Inc. | -3.780% | 0.671% | 4.651% | -13.211% | 7.219% | -86.657% | -72.110% |
| OncoCyte Corp | -3.610% | - | - | - | - | - | - |